Abstract

PurposeThe aim of this multi-center study was to assess the diagnostic capability of visual assessment in L-methyl-11C-methionine positron emission tomography (MET-PET) for differentiating a recurrent brain tumor from radiation-induced necrosis after radiotherapy, and to compare it to the accuracy of quantitative analysis.MethodsA total of 73 brain lesions (glioma: 31, brain metastasis: 42) in 70 patients who underwent MET-PET were included in this study. Visual analysis was performed by comparison of MET uptake in the brain lesion with MET uptake in one of four regions (around the lesion, contralateral frontal lobe, contralateral area, and contralateral cerebellar cortex). The concordance rate and logistic regression analysis were used to evaluate the diagnostic ability of visual assessment. Receiver-operating characteristic curve analysis was used to compare visual assessment with quantitative assessment based on the lesion-to-normal (L/N) ratio of MET uptake.ResultsInterobserver and intraobserver κ-values were highest at 0.657 and 0.714, respectively, when assessing MET uptake in the lesion compared to that in the contralateral cerebellar cortex. Logistic regression analysis showed that assessing MET uptake in the contralateral cerebellar cortex with brain metastasis was significantly related to the final result. The highest area under the receiver-operating characteristic curve (AUC) with visual assessment for brain metastasis was 0.85, showing no statistically significant difference with L/Nmax of the contralateral brain (AUC = 0.89) or with L/Nmean of the contralateral cerebellar cortex (AUC = 0.89), which were the areas that were the highest in the quantitative assessment. For evaluation of gliomas, no specific candidate was confirmed among the four areas used in visual assessment, and no significant difference was seen between visual assessment and quantitative assessment.ConclusionThe visual assessment showed no significant difference from quantitative assessment of MET-PET with a relevant cut-off value for the differentiation of recurrent brain tumors from radiation-induced necrosis.

Highlights

  • Brain tumors overexpress a variety of L-amino acid transporters [1], and L-methyl-11Cmethionine (MET) is useful positron emission tomography (PET) tracer for imaging in neurooncology [2, 3]

  • Logistic regression analysis showed that assessing MET uptake in the contralateral

  • Visual versus Qualitative Assessment for methionine positron emission tomography (MET-PET) in Brain Tumor cerebellar cortex with brain metastasis was significantly related to the final result

Read more

Summary

Introduction

Brain tumors overexpress a variety of L-amino acid transporters [1], and L-methyl-11Cmethionine (MET) is useful positron emission tomography (PET) tracer for imaging in neurooncology [2, 3]. The uptake of MET with recurrence due to tumor cells is different from that in radiation-induced injury where only passive diffusion across the broken blood-brain barrier occurs [7,8,9,10]. Terakawa et al showed that the optimal cut-off value was different for metastatic brain tumors (L/Nmean: 1.41, sensitivity 79% and specificity 75%) and gliomas (L/Nmean: 1.58, sensitivity 75% and specificity 75%) [7]. MET-PET is useful for identifying tumor recurrence after radiation, the adopted L/N cut-off ratios as well as the type of standardized uptake value (SUV) used in calculating the ratio (mean or maximum) varies according to the nature of the primary lesion [7, 11]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call